ClinChoice
Latest round
- Series E
Last raised
- Jul 2022
Total raised
- $214M
Investors
- 11
About ClinChoice
Founded in 2007 and based in Beijing, China, ClinChoice operates as a contract research organization that provides the International Council for Harmonisation(ICH) Good Clinical Practice(GCP) research services to the pharmaceutical, biotechnology, and medical device industries, with over 1800 clinical research professionals in more than 50 cities and 7 countries around the world. Ling Zhen is the CEO and chairman of the board of the company, and he was a partner at the Draper Dragon Venture Group. The company's main business includes clinical operations, project management, biostatistics, data management, statistical programming, regulatory affairs, medical affairs, feasibility studies, human genetic resources' management, clinical safety management, clinical trial site management, natural medicine/Chinese medicine, and clinical phase I services. The company's therapeutic areas include oncology, neurology, metabolism, respiratory, autoimmune, ophthalmology, musculoskeletal, urology, anti-infective, and rare diseases.
Who invested in ClinChoice
11 investors across 7 rounds
See all investors in ClinChoice
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Jul 5, 2022
Amount
$150M
Investors
Series D
Oct 25, 2019
Amount
$62M
Investors
Series C
Mar 1, 2016
Amount
Undisclosed
Investors
Series B
Mar 1, 2015
Amount
Undisclosed
Investors
Series A
Dec 31, 2009
Amount
$0.3M
Investors
Angel
Jan 1, 2008
Amount
Undisclosed
Investors
Seed
Dec 31, 2007
Amount
$1.2M
Investors
Questions about ClinChoice
Who invested in ClinChoice?
ClinChoice has 11 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ClinChoice raised?
ClinChoice has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did ClinChoice last raise money?
ClinChoice's most recent round on record is a Series E, in Jul 2022.
What does ClinChoice do?
Founded in 2007 and based in Beijing, China, ClinChoice operates as a contract research organization that provides the International Council for Harmonisation(ICH) Good Clinical Practice(GCP) research services to the pharmaceutical, biotechnology, and medical device industries, with over 1800 clinical research professionals in more than 50 cities and 7 countries around the world.
Where is ClinChoice headquartered?
ClinChoice is headquartered in Shanghai, China.
Which VCs invest in companies like ClinChoice?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at ClinChoice's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like ClinChoice? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.